Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 12.959\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CC(C)n1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2
b. Cc1ccc(/C=C(/NC(=O)c2ccccc2)C(=O)NCCc2c[nH]c3ccccc23)o1
Answer: a. CC(C)n1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)n1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2
CC(C)n1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2
N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide